Duke Debates Hematologic Malignancies 2024
Keynote Speaker:
Public
Advanced Practice Provider Symposium
Save the Date!
Duke Cancer Review
Save the Date!
Targeted Therapy in Early Stage Lung Cancer: A Surgery Perspective
Speaker: Erin Fulk, PA
Learning Objectives
- Identify driver mutations that are important in early stage disease..
- Discuss benefit of biopsy for identification.
- Assess for surgical resection.
- Determine the order of treatment.
- Recognize surgical management of patients after targeted therapy.
- Explain role of surgery for metastatic disease.
New Anticancer Treatments 2022
Speakers: Olivia White, PharmD and Jessica Goldsby, PharmD
Learning Objectives:
Duke Cardio-Oncology Symposium
With leading experts in the field, the Duke Cancer Network is once again collaborating with the Duke Cancer Institute and Duke Heart Center to provide a stimulating education activity focused exclusively on cardio-oncology, an intersection between cardiology and oncology. Using case studies to highlight critical moments in the prevention, screening, assessment, management and follow-up of cancer patients with cardiovascular risk and disease, this program will prepare participants to utilize practical resources to optimize patient care throughout the cancer continuum.
22nd Annual Duke Debates: Controversies in the Management of Patients with Hematologic Malignancies
This annual event brings together experts in the field of hematologic malignancies to debate and discuss advances in treatment for these cancers, novel treatment options, and debate current treatment paradigms. There is a mini session focusing on the management of immunotherapy and its use in solid tumors as well.